DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Von Minckwitz G, Procter MJ, De Azambuja E. et al.
Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer.
N Engl J Med 2017;
DOI: 10.1056/NEJMoa1703643.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.